Gabriel Rinnerthaler
- Oncology top 5%
- Molecular Biology
- Cancer Research top 5%
- Cell Biology top 5%
- Pulmonary and Respiratory Medicine top 10%
- Co-authors
- Richard GreilSimon Peter GampenriederJ. Victor SmallBenjamin GeigerHorst HinssenHeinz FaulstichHubert HacklLukas Weiß
- Topics
- Advanced Breast Cancer Therapies (25 papers)Breast Cancer Treatment Studies (22 papers)HER2/EGFR in Cancer Research (21 papers)
- Cited by
- OncologyCancer ResearchCell Biology
- Journals
- Journal of Clinical OncologySHILAP Revista de lepidopterologíaThe Journal of Cell Biology
- Partner nations
- AustriaGermanyUnited States
In The Last Decade
Gabriel Rinnerthaler
74 papers receiving 1.7k citations
Peers
Comparison fields: 5 of 116
- Oncology 755
- Molecular Biology 579
- Cancer Research 414
- Cell Biology 341
- Pulmonary and Respiratory Medicine 316
Countries citing papers authored by Gabriel Rinnerthaler
This map shows the geographic impact of Gabriel Rinnerthaler's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gabriel Rinnerthaler with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gabriel Rinnerthaler more than expected).
Fields of papers citing papers by Gabriel Rinnerthaler
This network shows the impact of papers produced by Gabriel Rinnerthaler. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gabriel Rinnerthaler. The network helps show where Gabriel Rinnerthaler may publish in the future.
Co-authorship network of co-authors of Gabriel Rinnerthaler
This figure shows the co-authorship network connecting the top 25 collaborators of Gabriel Rinnerthaler. A scholar is included among the top collaborators of Gabriel Rinnerthaler based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gabriel Rinnerthaler. Gabriel Rinnerthaler is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 0 | |
| 3 | 0 | |
| 4 | 6 | |
| 5 | 2 | |
| 6 | 7 | |
| 7 | 10 | |
| 8 | 5 | |
| 9 | Treatment Landscape for Patients with HER2-Positive Metastatic Breast Cancer: A Review on Emerging Treatment Options | 1 |
| 10 | 5 | |
| 11 | 151 | |
| 12 | 3 | |
| 13 | 26 | |
| 14 | 13 | |
| 15 | 18 | |
| 16 | 6 | |
| 17 | 6 | |
| 18 | 1 | |
| 19 | Hypertension as a predictive marker for bevacizumab in metastatic breast cancer: results from a retrospective matched-pair analysis. | 31 |
| 20 | 150 |
About Gabriel Rinnerthaler
Gabriel Rinnerthaler is a scholar working on Cancer Research, Oncology and Pulmonary and Respiratory Medicine, having authored 82 papers that have together received 1.7k indexed citations. Recurring topics across this work include Advanced Breast Cancer Therapies (25 papers), Breast Cancer Treatment Studies (22 papers) and HER2/EGFR in Cancer Research (21 papers). The work is most often cited by research in Oncology (755 citations), Cancer Research (414 citations) and Cell Biology (341 citations). Gabriel Rinnerthaler has collaborated with scholars based in Austria, Germany and United States. Frequent co-authors include Richard Greil, Simon Peter Gampenrieder, J. Victor Small, Benjamin Geiger, Horst Hinssen, Heinz Faulstich, Hubert Hackl, Lukas Weiß, Florian Huemer and Theresa Westphal. Their work appears in journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and The Journal of Cell Biology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.